Industry experts predict that specialty pharmaceuticals could account for up to 47% of a health plan�s total drug spend by 2020.

The specialty drug marketplace is expected to grow exponentially over the next several years both in utilization and in spend. Such rapid expansion presents a host of new challenges-- and opportunities-- for payer organizations and PBMs. This conference explores key advances in specialty pharmacy for optimizing cost management, medication adherence, patient engagement, benefit design, site of care channels, technology and developing new collaborations with industry stakeholders.

2018 Case Studies & Value Deliverables

Our comprehensive conference agenda provides learning opportunities through carefully curated case studies, panels, and small group roundtable sessions.

Discover in-depth solutions and presentations from health plan professionals, including PBM and PBA specialists.

  • Navigating the Specialty Drug Lexicon and how to effectively integrate specialty pharmacy into your formulary
  • Current PBM business model and shifts in primary sources of gross profit
  • Overview of Cost Drivers and Control Strategies and how to accomplish greater impact on Cost Reductions
  • Utilization Management Reform and Practices
  • Designing and implementing a Successful Medical Benefit Drug Management Plan
  • Medical Benefit vs. Pharmacy Benefit
  • Managing rare conditions with the ascent of Orphan Drugs
  • Gene Therapy Pipelines
  • Improving Adherence
  • Seizing Key Opportunities in Specialty Lite

Examine thought-provoking case studies and benefit from small-group, interactive discussions while networking with peers and experts as you share strategies to tackle key challenges facing specialty pharmacy:

  • Analyzing Top Specialty Drug Growth Categories and Strategies to Balance Costs vs. Outcomes
  • Latest Advances and Winning Strategies for Favorable Oncology Patient Outcomes
  • New ways to Fight HIV and how to best promote adherence and positive outcomes
  • Autoimmune Disorders Pipeline Update and why they should be added to your formulary
  • Inflammatory Diseases Assessment: Health plan utilization, cost, member cost-share, pharmacy and medical benefit spending
  • 2017 Speaking Faculty
    DST Pharmacy Solutions

    AJ Ally, RPh, MBA

    Vice President, Clinical Strategy and Programs
    National Association of Specialty Pharmacy

    Sheila Arquette, RPh

    Executive Director
    MedImpact Healthcare Systems, Inc.

    Steven G. Avey, RPh, MS, FAMCP

    Vice President, Specialty Programs
    Duke University

    Gregory Daniel, PhD, MPH

    Deputy Director
    Highmark Inc.

    Leah King, PharmD, JD

    Manager of Pharmacy Strategy
    Alignment Healthcare

    Ruby Liu, BA, PharmD

    Director of Pharmacy
    PricewaterhouseCoopers LLP

    Greg Mansur

    Principal, Global Human Resource Services
    University of Arizona Cancer Center

    Ali McBride, PharmD, MS, BCPS

    Clinical Coordinator of Hematology & Oncology,
    Blue Cross Blue Shield of Rhode Island

    Donna Paine, PharmD, MBA

    Clinical Pharmacy Specialist
    Accredo Health Group - An Express Scripts Company

    Meghan Pasicznyk, PharmD, MBA

    Director of Specialty Market Development
    Children's Medical Center

    Victoria Rodino

    Senior Manager, Virtual Health Programs
    Cleveland Clinic Employee Health Plan

    Bruce Rogen, MD, MPH, FACP

    Chief Medical Officer
    Blue Cross Blue Shield of Michigan

    Elizabeth Saltzman, PharmD

    Manager, Specialty Pharmacy Utilization Management
    Cleveland Clinic Employee Health Plan

    Jeffrey Schmitt, RPh, BS, PharmD

    Director, Pharmacy
    Banner Health

    Melissa Skelton Duke, PharmD, MS BCPS

    Senior Director, Specialty and Home Delivery Pharmacy Services
    Premera Blue Cross

    Neal S. Sofian

    Director of Member Engagement
    Pharmacy HIT

    Shelly Spiro, RPh, FASCP

    Executive Director
    Avella Specialty Pharmacy

    Eric Sredzinski, Pharm.D., AAHIVP

    EVP, Clinical Affairs & Quality Assurance Pharmacy Program Director
    Deloitte Consulting LLP

    George Van Antwerp

    Senior Manager
    2017 Supporting Organizations
    • Strategies for Combatting Rising Costs of Specialty Pharmaceuticals
    WHO SHOULD ATTEND:

    This event is designed for professionals specializing in:

    • Specialty Pharmacy Programs & Administration
    • Specialty Drug Management
    • Pharmacy Management
    • Pharmacy Care management
    • Pharmacy Network Administration
    • Pharmacy Benefit Management
    • Medication Therapy Management
    • Oncology
    • Clinical Pharmacy Services
    • Formulary Management
    • Disease Management
    • Utilization Management
    • Member Engagement
    • Benefit Design

    Types of Organizations:

    • Health Plans
    • Provider Sponsored Health Plans
    • PBMs
    • ACOs
    • Integrated Health Networks
    • Federal & State Programs
    • Specialty drug & technology solutions providers
    • Pharmaceutical manufacturers
    • Retail Pharmacies